Radiation, immunotherapy & chemo team up to shrink tumors before lung cancer surgery
NCT ID NCT07309952
Summary
This study is testing a three-part treatment to shrink tumors in people with a specific type of advanced lung cancer before they have surgery. It combines a targeted, high-dose radiation treatment (SBRT) with an immunotherapy drug (sintilimab) and standard chemotherapy. The main goal is to see if this approach can reduce cancer in hard-to-treat lymph nodes, making more patients eligible for potentially curative surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.